Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis

Thrombosis and Haemostasis

Volumn 81, Issue 5, 1999, Pages 676-679

  Franco, R F ^a,b,e   Reitsma, P H ^a   Lourenco D ^c   Maffei, F H ^a   Morelli, V ^c   Tavella, M H ^a   Araujo A G ^a   Piccinato, C E ^d   Zago, M A ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Faculty of the Medicine   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13;

ADULT; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; HEART INFARCTION; HEART PROTECTION; HEREDITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0032910569     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614552     Document Type: Article

References (17)

1. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-44.
2. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78: 297-301.
3. Dählback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. PNASUSA 1993; 90: 1004-8.
4. Bertina R, Koeleman B, Koster T, Rosendaal F, Dirven R, De Ronde H, van der Velden P, Reitsma P. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
5. Poort SW, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
6. Mikkola H, Syrjälä M, Rasi V, Vahtera E, Hämäläinen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation factor XIII; two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-25.
7. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
8. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ. Factor XIII Val34Leu. A novel association with primary intracerebral hemorrhage. Stroke 1998; 29: 813-6.
9. Kangsadalampai S, Board PG. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 1998; 92: 2766-70.
10. Kohler HP, Ariëns RAS, Whitaker P, Grant PJ. A common coding polymorphism in the FXIII A-subunit gene (FXIII VAL34LEU) affects cross-linking activity. Thromb Haemost 1998; 80: 704.
11. Winter M, Gallimore M, Jones DW. Should factor XII assays be included in thrombophilia screening? Lancet 1995; 346: 52.
12. Pandita D, Steen P, Potti A. Risk factors for deep venous thrombosis of the upper extremities. Ann Int Med 1997; 127: 1129.
13. Koster T, Rosendaal FR, Briët E, Vandenbroucke JP. John Hageman's factor and deep-vein thrombosis: Leiden Thrombophilia Study. Br J Haematol 1994; 87: 422-4.
14. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y. A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998; 91: 2010-4.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
16. Woolf B. On estimating the relation between blood group and disease. Am J Hum Genet 1955; 19: 251.
17. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77: 818-21.